Trial record 18 of 96 for:    Open Studies | "Refractive Errors"

Ocular Response Analyzer Assessment of Intraocular Pressure and Corneal Biomechanical Properties in Myopic and Anisometropic Patients Under Atropine Treatment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Far Eastern Memorial Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00658502
First received: April 11, 2008
Last updated: April 14, 2008
Last verified: March 2008
  Purpose

Our study has three parts has three parts, and the main aim of the study is to find out if corneal hysteresis was associated with myopia or even a predictor of myopia poor control predictor:

  • Part 1 of our study: patients with anisomeropia whose spherical equivalent refraction as measured by cycloplegic autorefraction between the two eyes differ greater than 1.5 D.
  • Part 2 of our study: Minus spherical equivalent refraction as measured by cycloplegic autorefraction.
  • Part 3 of our study: patients with minus spherical equivalent refraction as measured by cycloplegic autorefraction who are under regular atropine for the treatment of myopia;patients who are prescribed with atropine treatment are in need of myopia control instead of for research interest

Condition
Myopia
Anisometropia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Ocular Response Analyzer Assessment of Intraocular Pressure and Corneal Biomechanical Properties in Myopic and Anisometropic Patients Under Atropine Treatment

Resource links provided by NLM:


Further study details as provided by Far Eastern Memorial Hospital:

Primary Outcome Measures:
  • axial length, corneal hysteresis [ Time Frame: 3 month ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Refractive error, visual acuity, , intraocular pressure, , and corneal thickness [ Time Frame: 3 month ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: March 2008
Estimated Study Completion Date: August 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)

  Eligibility

Ages Eligible for Study:   6 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

age under 25 year old with or without myopia

Criteria

Inclusion Criteria:

  1. Normal ocular health other than myopia or anisometropia
  2. In good general health with no history of prematurity or cardiac or significant respiratory diseases
  3. No allergy to atropine, tropicamide, proparacaine, and benzalkonium chloride
  4. No previous or current use of contact lenses, bifocals, progressive addition lenses
  5. No amblyopia or manifest strabismus, including intermittent tropia

Exclusion Criteria:

  1. presence of keratoconus or other corneal disease
  2. previous eye drops usage except Atropine
  3. major ocular surgery history (including refractive surgery, scleral buckle, glaucoma filtering, cornea transplant, cataract and vitreoretinal surgery)
  4. presence of other ocular conditions such as glaucoma, uveitis, or other ocular inflammatory or vitreoretinal diseases.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00658502

Contacts
Contact: Shu-Wen Chang, MD 886-8966-7000 ext 2601 swchang@ntu.edu.tw

Locations
Taiwan
Far Eastern Memorial Hospital Recruiting
Pan-chiao, Taipei county, Taiwan, 220
Contact: Shu-Wen Chang, MD    886-8966-2000 ext 2601    swchang@ntu.edu.tw   
Principal Investigator: Shu-Wen Chang, MD         
Sponsors and Collaborators
Far Eastern Memorial Hospital
  More Information

No publications provided

Responsible Party: Shu-Wen Chang/Far Eastern Memorial Hospital, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT00658502     History of Changes
Other Study ID Numbers: FEMH97006
Study First Received: April 11, 2008
Last Updated: April 14, 2008
Health Authority: Taiwan: Institutional Review Board

Additional relevant MeSH terms:
Anisometropia
Myopia
Refractive Errors
Eye Diseases

ClinicalTrials.gov processed this record on July 29, 2014